Current management of patients with ST elevation myocardial infarction in Metropolitan Beijing, China

Shou -Yan Zhang; Da -Yi Hu; Yi -Hong Sun; Jin- Gang Yang
August 2008
Clinical & Investigative Medicine;Aug2008, Vol. 31 Issue 4, pE189
Academic Journal
Purpose: To assess clinical practices and in-hospital outcomes of patients with ST elevation myocardial infarction (STEMI) in Beijing, China. Methods: This study was a prospective multicentre registry study in Metropolitan Beijing, China. Demographics, delay time, management strategy and in-hospital outcome data were collected from patients with STEMI enrolled in 19 hospitals. Results: A total of 803 patients (mean age 61±13 yr ,22% women and 42.1% ⩾ 65 yr) with STEMI were enrolled. More than half had a history of hypertension (50.4%) and current smoking (55.2%). Six hundred and fifty patients (80.9%) received reperfusion trerapy: 124 (15.4% ) treated with thrombolysis and 526 (65.5% ) with primary percutaneous coronary intervention (PCI). The median door-toneedle time for thrombolysis was 83 min and door-toballoon time for primary PCI was 132 min. Only 7% of patients treated with thrombolysis met the guidelines goal of the door-to-needle time ⩽ 30min and 22% of patients had PCI performed in ⩾ 90 min. Aspirin was prescribed in 97.8% of patients, low molecular weigh heparin in 92%, statins in 91.0%, β-blockers in 76.7%, ACE inhibitors in 73.5%, clopidogrel in 89.7% and GP IIb/IIIa antagonists in 19.3%. In-hospital mortality was 5.4%. Conclusion: Recommended Clinical Guidelines treatments are largely implemented in patients with STEMI in Beijing. However, many patients were not reperfused within the recommended times. There remains important potential for improvement in the administration of reperfusion therapy.


Related Articles

  • Prevalence of risk factors of ST segment elevation myocardial infarction in Turkish patients living in Central Anatolia. Aygül, Nazif; Özdemir, Kurtuluş; Abacı, Adnan; Meryem Ülkü Aygül; Düzenli, Mehmet Akif; Vatankulu, Mehmet Akif; Yazıcı, Hüseyin Uğur; İbrahim Özdoğru; Karakaya, Ekrem // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Feb2009, Vol. 9 Issue 1, p3 

    Objective: There is not enough available data in our country about the prevalence of risk factors for ST-elevation myocardial infarction (STEMI), which has the highest in-hospital mortality rate within subtypes of acute coronary syndromes. Therefore, in this study, we aimed to evaluate the...

  • Optimal medical therapy proves its merit. Musunuru, Kiran; Blumenthal, Roger S. // Cardiology Today;Jun2008, Vol. 11 Issue 6, p10 

    The author expresses his views regarding COURAGE, a nuclear substudy which demonstrated no difference in rates of myocardial infarction and death for coronary artery disease (CAD) patients that was published in March 2008. The author discussed several ways on how to interpret the findings of...

  • Effects of Xuezhikang Capsule on High Risk Population in Chinese Coronary Secondary Prevention Study (CCSPS) and the Enlightenment from It. Xu Zhi-min // Chinese Journal of Integrative Medicine;Jun2006, Vol. 12 Issue 2, p87 

    The article discusses the effects of Xuezhikang (XZK) Capsule on high risk population in Chinese coronary secondary prevention study (CCSPS). CCSPS is one of the key items of the Ninth Five-year Plan of China. Patients with definite history of myocardial infarction were studied and followed up...

  • DIAGNOSTIC AND IMAGING TECHNIQUES. Addala, S.; Grines, C. L.; Dixon, S. R. // Current Medical Literature: Interventional Cardiology Monitor;2004, Vol. 11 Issue 3, p69 

    Presents the article "Predicting Mortality in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutanous Coronary Intervention," by S. Addala, C. L. Grines, S. R. Dixon, and colleagues.

  • Clinical profile of acute myocardial infarction patients in the absence of significant coronary artery disease. Pasupathy, S.; Tavella, R.; Arstall, M.; Chew, D.; Worthley, M.; Zeitz, C.; Beltrame, J. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS142 

    No abstract available.

  • Myocardial Infarction in a Patient with a Hageman (Factor XII) Defect. Glueck, Helen I.; Roehll Jr., Walter // Annals of Internal Medicine;Feb66, Vol. 64 Issue 2, p390 

    Presents a case report of the occurrence of myocardial infarction in a patient with an absolute deficiency of the Hageman factor (XII). Information on the patient; Results of the examination of the patient; Clotting studies.

  • Stents may be more beneficial for myocardial infarction.  // Modern Medicine;Sep98, Vol. 66 Issue 9, p30 

    Presents abstract of the articles `Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction,' by H. Suryapranata, A.W.J. van't Hof, et al and `Primary stenting in acute myocardial infarction: the promise and the proof (editorial),'...

  • Effects of Hyaluronidase Administration of Myocardial Ischemic Injury in Acute Infarction. Maroko, Peter R.; Davidson, Dennis M.; Libby, Peter; Hagan, Arthur D.; Braunwald, Eugen // Annals of Internal Medicine;Apr75, Vol. 82 Issue 4, p516 

    Examines the effectiveness of hyaluronidase administration on myocardial ischemic injury in acute infarction patients. Assessment of the rate of resolution of ST segment elevation using 35-electrode precordial mapping method; Impact of hyaluronidase on myocardial ischemic injury patients;...

  • Low BP associated with increased risk for stroke, MI. Raible, Eric // Cardiology Today;Jun2009, Vol. 12 Issue 6, p15 

    The article discusses research which found that coronary artery disease patients who also suffer low blood pressure face higher risk for stroke and myocardial infarction.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics